Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: drdan who wrote (1997)	6/28/1998 5:42:00 PM
From: Striyker	Read Replies (1) \| Respond to of 5402

REPOST: drdan, please don't take this the wrong way, but if this was a dumb question then just tell me "No I don't think that is a very good idea and this is why...", but please don't ignore me. I don't undestand why we can spend hours responding to Rumpswabs, but when a long asks a question, dumb or not, they get ignored... No I'm not mad and mean no disrespect in any way, but I don't post very much and am still learning, so it would be nice to be responded to when I ask a question. LOL, Striyker drdan, honest question here. I don't know anything about pharm firms, but can we get one or two company names that might be interested in PHER-O2 and contact there CEO's, to get there take on SGNC? I don't know if they would be willing to comment on whether or not they would buy in to SGNC, but would be interesting to see what they have to say. Maybe you or chirodoc could call, since you have the most knowledge and find out what they would be looking for in SGNC before they bought in and what kind of time frame we could be looking at. AIMO, Striyker